Renal Benefits of CO2 as a Contrast Media for EVAR Procedures: New Perspectives on 1 Year Outcomes.
Marco BusuttiAlice SensoniAndrea VacircaChiara AbenavoliChiara DonadeiAnna Laura Croci ChiocchiniMatteo RighiniGiorgia ComaiAlessia PiniGianluca FaggioliEnrico GallittoGaetano La MannaMauro GargiuloPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
Evaluating the safety and the renal impact of the administration of CO2, compared to Iodinate Contrast Medium, in EVAR procedures represents a first step in order to further tayloring medical procedures on patients characteristics. Our findings can guide the clinicians and surgeons in the procedures choice, not considering only the immediate effect of ICM on renal function but also the potential long-term effects.